Compare HCA Health Inc (HCA) vs Las Vegas Sands Corp. (LVS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
HCA Health Inc vs Las Vegas Sands Corp. — how do they compare? HCA Health Inc trades at $443.69 (market cap $96.35B), while Las Vegas Sands Corp. trades at $36.42 (market cap $23.38B). The key difference: HCA Health Inc is far larger — about 4.1× Las Vegas Sands Corp.'s market cap, and Las Vegas Sands Corp. pays the higher dividend (3.32%). Which is the better fit depends on your goals — on Pluang, investors hold HCA Health Inc for 76 Days and Las Vegas Sands Corp. for 72 Days on average.
| HCA | LVS | |
|---|---|---|
Market Cap | $96.35B | $23.38B |
Volume | 1,079,453 | 6,994,661 |
Sector | Health | Consumer Cyclical |
52-Week High | $545.13 | $69.49 |
52-Week Low | $361.32 | $35.81 |
Typical Hold Time | 76 Days | 72 Days |
Enterprise Value | $146.88B | $35.27B |
Dividend Yield | 0.7% | 3.32% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
HCA Healthcare (HCA) trades at $439.17, up 1.61% on the day, with a bullish technical signal and strong fundamentals. The stock shows consistent revenue growth, reaching $75.6B in 2025, and has beaten EPS estimates for three consecutive quarters. Analyst consensus is bullish with a $461.12 price target, supported by solid cash flow from operations of $12.64B and a net income margin of 8.77%.
The outlook remains positive given earnings momentum and operational efficiency, but risks include ongoing legal investigations and high debt levels. Upside potential exists if the company maintains its earnings beat streak and manages payer-mix challenges effectively.
LVS trades at $35.81, down 1.38% today, with a bearish technical signal from moving averages but bullish oscillators. The company reported revenue of $13.02B in 2025 with a net income margin of 12.59%, and recent earnings show mixed results with a Q2 2026 miss. Analysts maintain a strong buy consensus with a $59.78 price target, indicating significant upside potential from current levels.
The outlook for LVS is positive based on solid fundamentals and analyst optimism, but risks include high debt levels and reliance on Macao's tourism sector. Near-term performance may hinge on Q3 2026 earnings and ongoing stock repurchases, while long-term growth is supported by non-gaming expansions and community initiatives in Macao.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About HCA Health Inc
HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the U.S. As of December 2021, the firm owned and operated 182 hospitals, 125 freestanding outpatient surgery centers, and a broad network of physician offices, urgent care clinics, and freestanding emergency rooms across nearly 20 states and a small foothold in England.
Read more on HCA →About Las Vegas Sands Corp.
Las Vegas Sands is the world's largest operator of fully integrated resorts, featuring casino, hotel, entertainment, food and beverage, retail, and convention center operations. The company owns the Venetian Macao, Sands Macao, Londoner, Four Seasons Hotel Macao, and Parisian in Macao, and the Marina Bay Sands resort in Singapore. Its Venetian and Palazzo Las Vegas in the U.S. asets were sold to Apollo and VICI for $6.25 billion in 2022. We expect Sands to open a fourth tower in Singapore in 2026. After the sale of its Vegas assets, the company will generate all its EBITDA from Asia, with its casino operations generating the majority of sales.
Read more on LVS →
